Embase™
Subject
Coverage• Alternative medicine• Biological science relevant to human
medicine• Biochemistry• Biomedical engineering and medical
instrumentation• Biotechnology• Clinical and experimental medicine• Drugs• Environmental science

File Type

Bibliographic

Features

Thesaurus

Controlled Term (/CT)

Alerts (SDIs)

Weekly (default) or biweekly

CAS Registry
Number® IdentifiersPage Images

STN® AnaVist™



Keep & Share




SLART




STN Easy®



0B

1B

2B

Learning Database

•
•
•
•
•
•
•
•
•
•

Structures

Forensic science
Hospital management
Industrial medicine
Medical devices
Occupational hygiene
Pediatrics
Pharmacy
Pharmacology and drug therapy
Pharmaco-economics
Public health

RecordContent• Bibliographic information• Controlled terms (Emtree drug and medical descriptors)• Drug trade names and their manufacturers• Medical device trade names and manufacturers (1998 to the present)• Approximately 80% of the records include abstracts• CAS Registry Numbers

File SizeMore than 36.4 million records (8/2019)

Coverage1947 to the present

Updates

Daily with over 4,000 records

Language

English

Database
Producer

In North America:
Elsevier B.V.
Bibliographic Databases
360 Park Avenue SouthNew York, NY 10010-1710
Phone: 212-989-5800
Fax:
212-633-3990
Email:
usembaseinfo@elsevier.com

3B

4B

5B

6B

7B

8B

In Europe and Rest of World(outside Japan):
Elsevier B.V.
E-products TeamRadarweg 29
Amsterdam 1043 NX
Netherlands
Phone: (+31) 20 485 3911
Fax:(+31) 20 485 2912
Email:
ebd-marketing@elsevier.com

In Japan:
Elsevier B.V.
Bibliographic Databases
1-9-15 Higashi-Azabu
Minato-ku Tokyo 106-0044
Japan
Phone: (+81)-3-5561-5031
Fax:(+81)-3-5561-5046
Email:
jpembaseinfo@elsevier.com

August 2019

2
EmbaseSourcesOver 8,500 journals from about 95 countries, including MEDLINE titles (approximately
95% of file)Books, conference proceedings, and reports (approximately 5% of file)

User Aids

Online Helps (HELP DIRECTORY lists all help messages available)
STNGUIDE
Embase Journal List is available at: http://www.embase.com/info/
Emtree Thesaurus (updated three times per year)

Clusters• ALLBIB• AUTHORS• BIOSCIENCE• CASRNS• COMPANIES• CORPSOURCE• ENVIRONMENT• FORMULATIONS• HEALTH• MEDICINE• MEETINGS• PHARMACOLOGY• PV• TOXICOLOGYSTN Database Clusters information (PDF).

PricingEnter HELP COST at an arrow prompt (=>).

9B

10B

11B

12B

August 2019

3
EmbaseSearch and Display Field Codes
The fields that allow left truncation are marked with an asterisk (*).
Search Field Name

SearchCode

Display
Codes

Search Examples

Basic Index * (contains single words
from the title (TI), abstract (AB),controlled term (CT), chemical name(CN), corporate name (CO), name of
product (NP), and gene number(GEN) fields, as well as CAS
Registry Numbers)None(or /BI)S STOMACH ULCER
S 51481-61-9
S FOOD(1W)DRUG ADMINISTR?
S ?SPRAY?

AB, CN, CO,
CT, GEN, NP,
RN, TI

Abstract *

/AB

AB

Accession Number/AN

Author (includes editor) (6)/AU

Author Identifier
Chemical Name (Drug or Medical
Device Trade Name) (1,2)
Chemical Name Segment *Clinical Trial Numbers/AUID/CN (or /TN)

Controlled Term (contains Medical
Descriptors, Drug Descriptors,
including major terms) (3)/CT

Corporate Name (Manufacturer)(2,4)/CO

Corporate Source (4,6)
Country of Publication (ISO code andtext)
Digital Object Identifier

/CS
/CY

S IMAGING STUD?/AB
S ?PHYSEM?/AB
S 85114254/AN
S 2005469912/AN
S 20151000029/AN
S JONES, E A/AUS O REILLY?/AU
S 0000-0003-4999-6753/AUIDS TAGAMET/CNS NEMBUTAL/CN (L) LABAZ/COS THIOGLYCOLATE/CNSS NCT00004730/NCT
S ISRCTN78047760/NCTS STOMACH ULCER/CT (L) DT/CTS *STOMACH ULCER/CTS LINDANE+ALL/CTS CISPLATIN/CT (L) IT/CTS PANCREAS DISEASE/CT
S ANIMAL EXPERIMENT/CT AND L1
S CALBIOCHEM/COS RESEARCH BIOCHEMICALS/COS UNIV ARIZ?/CSS FRANCE/CY
S JP/CY
S 10.1016/J.FCT.2013?/DOI
S 25368387/DN
S CONFERENCE/DT
S C/DTS SANDHOFF@UNI-BONN.DE/EML
S SANDHOFF DE/EML
S L1 AND ED>20041100
S L1 and EDAL>20091231
S L2 AND AB/FA
S 016/FSS CANCER/FSS MEDLINE/FS
S A02168/GEN
S LANCAO/ISN
S 0388-6107/ISN
S J CARD SURG/JTS JOURNAL OF CARDIAC SURGERY/JT
S L1 AND EN/LA
S 20090925/MD
S INSULIN/MTS NORWAY/MLS ASTELLAS/MO
S 2009/MY

DN
DT

/CNS
/NCT

Email Address (4)/DOI (or/FTDOI)/DN/DT(or /TC)/EML

Entry Date (5,7)
Entry Date MEDLINE (5,7)
Field Availability
File Segment (code and text)

/ED
/EDAL
/FA
/FS

Gene Number
International Standard (Document)
Number (ISBN, ISSN, CODEN)
Journal Title (contains full andabbreviated title)
Language (ISO code and text)
Meeting Date
Meeting Information
Meeting Location
Meeting Organizer
Meeting Year

/GEN
/ISN

Document Number
Document Type (code and text)

/JT
/LA
/MD
/MT
/ML
/MO
/MY

AN

AU, SO
AUID
CN

NCT
CT

CO
CS
CY
FTDOI, DOI

CS, EMLED
ED
Not displayed
FS

GEN
ISN, SO
JT, JTA, JTF,
SO
LA
MD, SO
MT, SO
ML, SO
MO, SO
MY, SO
August 2019

4
EmbaseSearch and Display Field Codes (cont’d)Search Field Name
Name of Product
Other Sources (10)Publication Date (5)Publication Year (5)Publisher
Publisher Item Identifier
Source (contains abbreviated journal
title, publication date, collation
information (volume, issue,
pagination, and number ofreferences), meeting information,
ISSN, ISBN, and CODEN)
Summary Language (ISO code andtext)
Supplementary Terms*
Title *
Update Date (5,8)
Update Date MEDLINE (5,8 )Update Date - Intellectual Indexing
Added (5,9)

SearchCode

Display
Codes

Search Examples

/NP
/OS
/PD
/PY
/PB
/PUI
/SO

S ACUSON 128?/NP
S 2004237519/OS
S 20040100-20050600/PD
S 2003-2004/PY
S ELSEVIER IRELAND/PB
S “S 0001-706X(96)00022-8”/PUIS HEMATOL PATHOL/SOS (1011-6788 AND 2004)/SONP
OSPD, SOPY, SO
PB
PUI
SO

/SL

S L3 AND EN/SL

SL

/ST
/TI
/UP
/UPAL
/UPI

S HIPPOCAMPUS/STS AMINO ACID#/TI
S UP20050119
S L1 and UPAL>20091231
S 20161208/UPI

ST
TI
ED
ED
UPI

(1) Medical device trade names are available from 1998 to the present.
(2) For data after mid-1998, you can use the (L) operator to link the trade names in /CN to manufacturer names in /CO.
(3) An online thesaurus is available in this field.
(4) Search with implied (S) proximity is available in this field.
(5) Numeric search field that may be searched with numeric operators or ranges.
(6) Use (L) to link AU CS pairs.
(7) ED is the entry date for Elsevier-created Embase records and specifically excludes records from the MEDLINE file segment. EDAL is
used for the entry date of Embase records plus MEDLINE file segment records.
(8) UP is the update date for Elsevier-created Embase records and specifically excludes records from the MEDLINE file segment. UPAL
is used for the update date of Embase records plus MEDLINE file segment records.
(9) UPI field is effective December 1, 2016.
(10) Frequently provides hyperlinks to errata and retractions.

Limiting Search Codes
Only an L-number for an answer set created in Embase may be limited.
Search Field Name
Animal subject
English language records
Female subject
Human subject
Major descriptor
Male subject

SearchCode (1)/NONHUMAN/ENGLISH/FEMALE/HUMAN/MAJOR/MALE

Search Examples
S L4/NON
S L1/MAJ,ENG (2)S L3/FEM
S L1/HUM
S L1/MAJ (3)S L2/MAL(1) The code may be abbreviated to the first three letters.
(2) An answer set may be limited to more than one subject area.
(3) Major terms may be searched directly in the Controlled Term (/CT) field by preceding the search term with an asterisk, e.g., S *LUNGEMBOLISM/CT.

August 2019

5
EmbaseSuper Search Fields
Enter a super search code to execute a search in one or more fields that may contain the desired information.
Super search fields facilitate crossfile and multifile searching. EXPAND may not be used with super search
fields. Use EXPAND with the individual field codes instead.
Search Field Name
Index Terms

SearchCode

FieldsSearched/CT, /ST/IT

Search Examples
S ANIMAL EXPERIMENT/IT

Display
Codes
CT, ST

Controlled Term (/CT) Thesaurus
All relationship codes may be used with both the SEARCH and EXPAND command in the Controlled Term(/CT) thesaurus.
Code
ALL
AUTO (1)
BT
HIE
KT
NOTE
NT
PFT
STD
UF
USE

Content
All associated terms(BT, SELF, QA, TYPE, NTYP, HNTE, RN, EC, UF, NT)
Automatic Relationship(SELF, USE)
Broader Terms(BT, SELF)
Hierarchy (Broader and Narrower Terms)(BT, SELF, NT)
Keyword Terms (multiword phrases containing term)(SELF, KT)
Notes associated with the term
(SELF, NOTE, HNTE, RN, EC)
Narrower Terms(SELF, NT)
Preferred Terms and Synonyms(SELF, USE, UF)Standard (Broader and Narrower Terms)(BT, SELF, NT)
Used For (Synonyms) (Forbidden Terms)(SELF, UF)
Use (Preferred Terms)(SELF, USE)

ExampleE JOINT INJURY+ALL/CT
E LINDANE+ALL/CT
E ARTICULAR TRAUMA+AUTO/CT
E ANEURYSM+BT/CT
E MYOPATHY+HIE/CT
E LYMPHOMA+KT/CT
E VIRILIZATION+NOTE/CTS STOMACH DISEASE+NT/CTS SCLEROTHROMBOSIS+PFT/CTS ALPHA AMYLASE + PFT/CT
E KIDNEY FAILURE+STD/CT
E ASPARAGINE+UF/CT
E ARTICULAR TRAUMA+USE/CT(1) Automatic relationship is SET OFF. When SET REL is ON, the result of EXPAND without any relationship code is the same as
described for AUTO.

Thesaurus Field Descriptors
Code

BT
EC
HNTE (1)KT
NT
NTYP (2)QA
RN
TYPE (3)UF
USE

Description
Self
Broader Term
Enzyme Commission Number
History Note
Keyword Term
Narrower Term
Term Name Type
Subheading abbreviation
CAS Registry Number
Term Type
Used For Term (Synonym)
Use (Preferred) Term

(1) Creation date for Preferred Terms, plus additional history notes. May also include scope notes describing how the Preferred Term is indexed.
(2) Applies to Preferred Terms only. Three possible values: MeSH descriptor, device trade name or drug trade name.
August 2019

6
Embase(3) Disease term, drug term device term or medical term.

August 2019

7
EmbaseDISPLAY and PRINT Formats
Any combination of formats may be used to display or print answers. Multiple codes must be separated by
spaces or commas, e.g., D L1 1-5 BIB ABS; D L1 TI,AU,SO,CS,AB. The fields are displayed in the orderspecified.
Hit-term highlighting is available for all searchable fields. Highlighting must be ON during SEARCH to use the
HIT, HITIND, KWIC, and OCC formats.
FormatContent

ExamplesAB
AN (1)AU
AUPB (2,4)
CN (TN) (1)CO (1)CP (2)CS
CT (1)CY
DN (2)
DOI (FTDOI)DT (TC)
ED (UP)
EML (2)FSFTDOI (2)GEN (1)ISN (2)JT (2)JTA (2)
JTF (2)
LA
MD (2)
ML
MO
MT
MY
NCT
NP (1)OS
PB
PD (2)PUI
PY (2)
RN (1)SL
SO
ST
TI (1)UPI (2,5)

Abstract
Accession Number
AuthorAuthors in Publication Order
Chemical Name (Drug Trade Name)
Corporate Name (Manufacturer)
Copyright MEDLINE (for unique MEDLINE records only)
Corporate Source
Controlled Term
Country of Publication (ISO names)
Document Number
Digital Object Identifier
Document Type
Entry Date (includes ED.FIR information when available)
Email Address
File Segment
Digital Object Identifier
Gene Number
International Standard (Document) Number
Journal Title
Journal Title, Abbreviated
Journal Title, Full
Language
Meeting Date
Meeting Location
Meeting Organizer
Meeting Information
Meeting Year
Clinical Trial Numbers
Name of Product
Other Sources
Publisher
Publication Date
Publisher Item Identifier
Publication Year
CAS Registry Number
Summary Language
SourceSupplementary Terms
Title
Update Date - Intellectual Indexing Added

D AB L4 1-5
D AN 1-15
D AU 5 6 8-10
D AUPBD CN L1
D 1-6 L2 CO
D 1 AN CP
D CS L11
D CT 1-17
D 1-7 CY
D DN
D DOI or D FTDOID DT 4-18 L3
D ED, D UP, D UPI
D EML
D FS 1-2
D DOI
D GEN
D 5,6 ISN
D JT
D JTA
D JTF
D LA 4 6 10
D MD
D ML
D MO
D MT
D MY
D NCT
D NP
D OS
D PB
D PD
D PUI
D JT PY
D RN 1-15 L2
D SL 1-5
D 5 L3 SO
D ST
D TI 50-70
D UPI 2

ABS
ALL

AB
AN, TI, AUPB, AU, AUID, CS, SO, DOI, PB, PUI, CY, DT, FS, OS, NCT, LA, SL,
ED (UP, UPI), AB, CT, ST, RN, CN, NP, CO, GEN
AU, AUID, CS (grouped in pairs)
AN, TI, AU, AUID, CS, SO, DOI, PB, PUI, CY, DT, FS, NCT, LA, SL, ED (UP, UPI)(BIB is the default)AN, compressed bibliographic data
ALL, delimited for post-processing
AB, with text labels
ALL, indented with text labels
BIB, indented with text labels
CT, ST, RN, CN, NP, CO, GEN

D ABS 1-10
D ALL 5-10

AU.CS
BIB
CBIB
DALL
IABS
IALL
IBIB
IND (1)

D AU.CSD BIB 1-10
D CBIBD DALLD IABSD IALLD IBIBD IND L2 1-10
August 2019

8
EmbaseDISPLAY and PRINT Formats (cont’d)FormatContent

Examples

SCAN (1,3)
TRIAL (TRI,
FREE, SAM) (1)

TI, CT, ST, RN, CN, NP, CO, GEN (random display without answer numbers)
TI, CT, ST, RN, CN, NP, CO, GEN

D SCAN
D 1-3 TRIAL

HIT
HITIND (1)KWIC
OCC (1)

Fields containing hit terms
IND
Hit term with 20 words on either side (KeyWord-In-Context)
Number of occurrences of hit terms and fields in which they occur

D HIT 5-10
D HITINDD KWIC 1-3
D OCC 1-6

(1) No online display fee for this format.
(2) Custom display only.
(3) SCAN must be specified on the command line, i.e., D SCAN or DISPLAY SCAN.
(4) If 100 or more authors are provided, only the first 99 are presented followed by et al.
(5) UPI field is effective December 1, 2016.

SELECT, ANALYZE, and SORT Fields
The SELECT command is used to create E-numbers containing terms taken from the specified field in ananswer set.
The ANALYZE command is used to create an L-number containing terms taken from the specified field in ananswer set.
The SORT command is used to rearrange the search results in either alphabetic or numeric order of thespecified field(s).
Field Name
Abstract
AuthorAuthor Identifier
Authors in Publication Order
CAS Registry Number
Chemical Name (Drug Trade Name)
Chemical Name and CAS Registry Number
Citation
Clinical Trial Numbers
CODEN
Controlled Term
Corporate Name (Manufacturer)
Corporate Source
Country of Publication
Document Number
Document Type
Email Address
Entry Date
Entry Date for MEDLINE
File Segment
Genbank Number
Gene Number
International Standard Book Number
International Standard (Document) Number
International Standard Serial Number
Journal Title
Journal Title, Abbreviated
Journal Title, Full
Language
Meeting Date
August 2019

Field CodeANALYZE/
SELECT (1)

AB
AU
AUID
AUPB
RN
CN (TN)
NAME
CHEM
CIT
NCT
CODEN
CT
CO
CS
CY
DN
DT
EML
ED
EDAL
FS
GENBANK
GEN
ISBN
ISN
ISSN
JT
JTA
JTF
LA
MD

Y
Y
Y
Y (9)
Y (2)
Y
Y (2)
Y (2)
Y (3,4)
Y
N
Y
Y
Y
Y
N
Y
Y
Y
Y
Y
Y (2)
Y
N
Y (5)
N
Y
Y (6)
Y (6)
Y
Y

SORT
N
Y
Y
N
N
Y
N
N
N
Y
Y
N
Y
Y
Y
Y
Y
N
Y
N
Y
N
Y
Y
N
Y
Y
Y
Y
Y
Y

9
EmbaseSELECT, ANALYZE, and SORT Fields (cont’d)Field Name
Meeting Information
Meeting Location
Meeting Organizer
Meeting Year
Name of ProductOccurrence Count of Hit Terms
Other Sources
Publication Date
Publication Year
Publisher Item Identifier
SourceSummary Language
Supplementary Terms
Title
Trade Name
Treatment CodeUpdate Date
Update Date for MEDLINE
Update Date - Intellectual Indexing Added

Field CodeANALYZE/
SELECT (1)

SORT

MT
ML
MO
MY
NP
OCC
OS
PD
PY
PUI
SO
SL
ST
TI
TN
TC
UP
UPAL
UPI

Y
Y
Y
Y
Y
N
Y
Y
Y
Y
Y (7)
Y
Y
Y (default)
Y
Y (8)
Y
Y
Y (10)

Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
N
Y
N
Y
Y
Y
Y
N
Y

(1) HIT may be used to restrict terms extracted to terms that match the search expression used to create the answer set, e.g., SEL HIT
RN.
(2) Appends /BI to the terms created by SELECT.
(3) SELECT HIT and ANALYZE HIT are not valid with this field.
(4) Extracts the first author, publication year, volume, and first page with a truncation symbol appended and /RE appended to the terms
created by SELECT.
(5) Selects or analyzes ISSN, ISBN, and CODEN with /ISN appended to the terms created by SELECT.
(6) Appends /JT to the terms created by SELECT.
(7) Selects or analyzes ISSN, ISBN, and CODEN with /SO appended to the terms created by SELECT.
(8) Appends /DT to the terms created by SELECT.
(9) Appends /AU to the terms created by SELECT.
(10) UPI field is effective December 1, 2016.

Sample Records
DISPLAY IALLEMBASE COPYRIGHT (c) 2017 Elsevier B.V. All rights reserved on STN
ACCESSION NUMBER:
20170513793 EMBASE
DOCUMENT NUMBER:
617320307
TITLE:
Erratum to: Fertility preservation with ovarian stimulationand time to treatment in women with stage II-III breast
cancer receiving neoadjuvant therapy (Breast Cancer
Research and Treatment, (2017), 165, 1, (151-159),
10.1007/s10549-017-4288-3).
AUTHORS IN PUB ORD: Chien, A. Jo (correspondence); Chambers, Julia; Mcauley,Fiona; Kaplan, Tessa; Letourneau, Joseph; Hwang, Jimmy;
Kim, Mi-Ok; Melisko, Michelle E.; Rugo, Hope S.; Esserman,
Laura J.; Rosen, Mitchell P.
AUTHOR:
Chien, A. Jo (correspondence); Mcauley, Fiona; Hwang,
Jimmy; Kim, Mi-Ok; Melisko, Michelle E.; Rugo, Hope S.;
Esserman, Laura J.
AUTHOR IDENTIFIERS: ORCID: http://orcid.org/0000-0003-2978-6249
CORPORATE SOURCE:
Helen Diller Family Comprehensive Cancer Center, Universityof California San Francisco, 1600 Divisadero St., Box 1710,
San Francisco, CA, 94115, United States. jo.chien@ucsf.edu
AUTHOR:
Chambers, Julia
CORPORATE SOURCE:
University of California San Francisco School of Medicine,Francisco, CA, United States.
AUTHOR:
Kaplan, Tessa
CORPORATE SOURCE:
Columbia University College of Physicians and Surgeons, New
York, NY, United States.
August 2019

10
EmbaseAUTHOR:
CORPORATE SOURCE:

Letourneau, Joseph; Rosen, Mitchell P.
Department of Obstetrics, Gynecology and Reproductive
Sciences, University of California San Francisco, San
Francisco, CA, United States.
SOURCE:
Breast Cancer Research and Treatment, (1 Aug 2017) Vol.
165, No. 1, pp. 161.
ISSN: 0167-6806; E-ISSN: 1573-7217 CODEN: BCTRD6
DIGITAL OBJECT ID: 10.1007/s10549-017-4350-1
PUBLISHER:
Springer New York LLC.
COUNTRY:
United States
DOCUMENT TYPE:
Journal; Errata; (Erratum)
FILE SEGMENT:Intellectual Indexing
016
CancerOTHER SOURCE:EMBASE 20170350460
LANGUAGE:
EnglishSUMMARY LANGUAGE:
EnglishENTRY DATE:Entered Embase: 21 Jul 2017
Last Updated on Embase: 24 Jul 2017
Indexing Added: 24 Jul 2017
First Entered Embase or Embase Alert: 21 Jul 2017
ABSTRACT: In the original publication of the article, the first author's given
and family names were swapped erroneously. The corrected first author's nameis given in this erratum. The original article was corrected.
CONTROLLED TERM:

Medical Descriptors:
Erratum*errorpriority journal

DISPLAY TRIAL
TI
Controlled multiplex PCR of enterotoxigenic Clostridium perfringens
strains in food samples.
CT
Medical Descriptors:
articlebacterial infection: DI, diagnosis
bacterium culture
clinical trial*clostridium perfringens
controlled study
food
food contamination*food poisoning: DI, diagnosis
gene
immunodiffusion
meat
nonhumannucleotide sequence*polymerase chain reaction
priority journal
standard
CT
Drug Descriptors:
alpha toxin
ampli taq
bacterial DNA
DNA polymerase
enterotoxin
unclassified drug
RN
(DNA polymerase) 37217-33-7
CN(1) ampli taq
CO(1) Perkin Elmer (Germany)NP(1) ABI 373A; (2) ABI 380A
CO(1) Applied Biosystems (Germany) ; (2) Applied Biosystems (Germany)
GEN EMBL M98037 referred number

DISPLAY of a Conference Review
August 2019

11
EmbaseAN
TI

0050779249 EMBASE
Abstracts Presented at the 31st Annual Meeting of the Arthroscopy
Association of North America.
SO
Arthroscopy - Journal of Arthroscopic and Related Surgery, (June 2012)
Vol. 28, No. 6, Supp. SUPPL. 1. Abstract Number: SS-01.
Meeting Info: 31st Annual Meeting of the Arthroscopy Association of North
America. Orlando, FL, United States. 17 May 2012-19 May 2012
ISSN: 0749-8063
PB
W.B. Saunders.
DT
Journal; Conference; (Conference Review)
FS
CONF
LA
EnglishEDEntered STN: Sep 2012
Last Updated on STN: Sep 2012
AB
The proceedings contain 77 papers. The topics discussed include: arthroscopic
treatment of labral tears in acetabular dysplasia: the role of the tonnis angle and its
effect on the outcomes; osteoplasty for cam type impingement is more accurate when
performed open than arthroscopic; traction injury risk in hip arthroscopy-duration oramount? an intraoperative nerve monitoring study; arthroscopic iliopsoas tendon releasein the treatment of internal snapping hip; hip arthroscopy in the older patient; fullarthroscopic TFCC repair: seven years experience and comparison of two methods;
arthroscopic wrist debridement and radial styloidectomy for late-stage scapholunate
advanced collapse wrist; arthroscopic tennis elbow release: outcomes correlated toassociated lesions; arthroscopic tennis elbow release: outcomes correlated to associatedlesions; and osteochondral lesions of the talus: a ten-year prospective clinicalexperience.

EXPAND in /CT field (Subheadings included)=> E LUNG EMBOLISM/CT
E#
FREQUENCYAT
TERM-------------E1
E2
E3
E4
E5
E6
E7
E8
E9
E10
E11
E12

23
1
23854
4
5231
5809
223
14
5032
706
1190
2380

LUNG EMBOLECTOMY/CT
LUNG EMBOLECTOMY: TH, THERAPY/CT
27 --> LUNG EMBOLISM/CT
LUNG EMBOLISM: CN, CONGENITAL DISORDER/CT
LUNG EMBOLISM: CO, COMPLICATION/CT
LUNG EMBOLISM: DI, DIAGNOSIS/CT
LUNG EMBOLISM: DM, DISEASE MANAGEMENT/CT
LUNG EMBOLISM: DR, DRUG RESISTANCE/CT
LUNG EMBOLISM: DT, DRUG THERAPY/CT
LUNG EMBOLISM: EP, EPIDEMIOLOGY/CT
LUNG EMBOLISM: ET, ETIOLOGY/CT
LUNG EMBOLISM: PC, PREVENTION/CT

EXPAND in /CT Thesaurus=> E JOINT INJURY+ALL/CT
E1
0BT5
emtree thesaurus/CT
E2
1BT4physical diseases, disorders and abnormalities/CT
E3
18
BT3
physical disease by anatomical structure/CT
E4
9649
BT2
musculoskeletal disease/CT
E5
8465
BT1
arthropathy/CT
E60BT5emtree thesaurus/CT
E7
1BT4physical diseases, disorders and abnormalities/CT
E8
3BT3physical disease by etiology and pathogenesis/CT
E9110813
BT2
injury/CT
E100BT5emtree thesaurus/CT
E11
1
BT4
physical diseases, disorders and abnormalities/CT
E12
18
BT3
physical disease by anatomical structure/CT
E13
9649
BT2
musculoskeletal disease/CT
E14
1667
BT1
musculoskeletal injury/CT
E15
1383
-->
joint injury/CT
HNTE Creation date 01 JAN 1984
E16
0UF
articular trauma/CT
August 2019

12
Embase
E17
E18
E19
E20
.....

0
0
2404
99

In North America
CAS
STN North America
P.O. Box 3012
Columbus, Ohio 43210-0012 U.S.A.
CAS Customer Center:Phone: 800-753-4227 (North America)
614-447-3700 (worldwide)Fax:
614-447-3751
Email:
help@cas.org
Internet: www.cas.org

August 2019

UF
UF
NT1
NT2

bone joint injury/CT
joint trauma/CT
ankle injury/CT
ankle dislocation/CT

In Europe
FIZ Karlsruhe
STN Europe
P.O. Box 2465
76012 Karlsruhe
Germany
Phone: +49-7247-808-555
Fax:+49-7247-808-259
Email:
helpdesk@fiz-karlsruhe.de
Internet: www.stn-international.com

In Japan
JAICI (Japan Association forInternational Chemical Information)
STN Japan
Nakai Building
6-25-4 Honkomagome, Bunkyo-ku
Tokyo 113-0021, Japan
Phone: +81-3-5978-3601 (Technical Service)+81-3-5978-3621 (Customer Service)
Fax:+81-3-5978-3600
Email:
support@jaici.or.jp (Technical Service)customer@jaici.or.jp (Customer Service)
Internet: www.jaici.or.jp